For citations:
FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children. Pediatric pharmacology. 2021;18(5):436. (In Russ.)
FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children. Pediatric pharmacology. 2021;18(5):436. (In Russ.)